These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions. Ray GM; Nawarskas JJ; Frishman WH Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus. Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468 [TBL] [Abstract][Full Text] [Related]
7. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice]. Er F; Erdmann E Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349 [TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stents for the treatment of in-stent restenosis: a clinical review. Yan BP; Ajani AE; Waksman R Cardiovasc Revasc Med; 2005; 6(1):38-43. PubMed ID: 16263355 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization. Liuzzo JP; Ambrose JA; Coppola JT J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242 [TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials? Ryan J; Cohen DJ; Pinto DS Coron Artery Dis; 2006 Dec; 17(8):667-71. PubMed ID: 17119374 [TBL] [Abstract][Full Text] [Related]
11. Update on drug-eluting coronary stents. Kipshidze NN; Tsapenko MV; Leon MB; Stone GW; Moses JW Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):953-68. PubMed ID: 16181039 [TBL] [Abstract][Full Text] [Related]
12. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Bose R; Gupta G; Grayburn PA; Laible EA; Kang MJ; Choi JW Am J Cardiol; 2007 Sep; 100(6):949-52. PubMed ID: 17826375 [TBL] [Abstract][Full Text] [Related]
13. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341 [TBL] [Abstract][Full Text] [Related]
14. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753 [TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels. Quizhpe AR; Feres F; de Ribamar Costa J; Abizaid A; Maldonado G; Costa R; Abizaid A; Cano M; Moreira AC; Staico R; Mattos LA; Tanajura LF; Chaves A; Centemero M; Sousa AM; Sousa JE Am Heart J; 2007 Aug; 154(2):373-8. PubMed ID: 17643591 [TBL] [Abstract][Full Text] [Related]
17. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063 [TBL] [Abstract][Full Text] [Related]
18. New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis. Vaina S; Ong AT; Serruys PW Minerva Cardioangiol; 2005 Oct; 53(5):341-60. PubMed ID: 16179880 [TBL] [Abstract][Full Text] [Related]